Cargando…
Second-line afatinib administration in an elderly patient with squamous cell carcinoma
INTRODUCTION: The majority of cases of lung cancer are still diagnosed at a late stage. At this stage, palliative therapeutic options including nonspecific cytotoxic drugs, targeted therapy, or immunotherapy can be utilized. In 2016, immunotherapy was approved in Europe for squamous cell carcinoma a...
Autores principales: | Hohenforst-Schmidt, Wolfgang, Zarogoulidis, Paul, Steinheimer, Michael, Benhassen, Naim, Sardeli, Chrysanthi, Stalikas, Nikos, Toitou, Melpomeni, Huang, Haidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367451/ https://www.ncbi.nlm.nih.gov/pubmed/28356747 http://dx.doi.org/10.2147/TCRM.S130816 |
Ejemplares similares
-
A retrograde y-stenting of the trachea for treatment of mediastinal fistula in an unusual situation
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2017) -
“Liquid elbows” due to afatinib administration
por: Zarogoulidis, Paul, et al.
Publicado: (2017) -
Tyrosine Kinase Inhibitors for the Elderly
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2016) -
Inhaled Immunotherapy Administration for Lung Cancer; Efficient? Certainly Possible
por: Sapalidis, Konstantinos, et al.
Publicado: (2018) -
Aerosol Immunotherapy with or without Cisplatin for metastatic lung cancer non-small cell lung cancer disease: In vivo Study. A more efficient combination
por: Sapalidis, Konstantinos, et al.
Publicado: (2018)